Search Results 291-300 of 1243 for 国外ai写作网站,ai 软件下载网站,网文写作ai,ai绘画 生成网站,ai语音克隆网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

1. Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer - Mayo Clinic

   This is a phase Ib study of PDR001 in combination with regorafenib in adult patients with previously treated metastatic microsatellite stable (MSS) colorectal ...

3. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection - Mayo Clinic

   The purpose of this study is to evaluate the safety and effectiveness of CP101 treatment in adults who had a Clostridum difficile Infection (CDI) recurrence ...

4. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

   Clinical Trials · Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) · More about research at ...

5. Effectiveness of Departmental Education on Reducing 5% Albumin Administration - Mayo Clinic

   The goal of this study is to better understand why anesthesia providers utilize albumin within the operative setting, to the area of clinical specialty, years ...

6. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

   Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) · Overview.

7. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

   This study is to assess the safety, tolerability, preliminary efficacy, and pharmacokinetics of APL-2 in subjects with warm Autoimmune Hemolytic Anemia (wAIHA) ...

8. A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome - Mayo Clinic

   The purpose of this study is to evaluate the impact of pitolisant on Excessive daytime sleepiness in patients with Prader-Willi syndrome. Participation ...

9. Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure - Mayo Clinic

   The purpose of this study is to evaluate the efficacy of CS Reducer implantation in patients with HFpEF and CMD on left ventricular filling pressures, ...

10. Maria E. Lozada - Training and Education - Center for Clinical and Translational Science (CCaTS)

    Profile of Maria E. Lozada, a student in the M.D.-M.S. Program at Mayo Clinic.